UNSPSC 51293502: Indatraline

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51293502

Definition

This classification denotes an antidepressant agent with the molecular formula C16H15Cl2N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4U40Y96J1Z, chemically known as 3-(3,4-dichlorophenyl)-n-methyl-1-indanamine hcl but generally known as indatraline, which bears US NIH Compound Identifier 126280. European Medicines Agency schedules Indatraline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08170MIG.

Read the full definition

The term INDATRALINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). INDATRALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule indatraline under HS 29214980 and SITC 51454. As of Q4 2014, INDATRALINE remains the US FDA Preferred Term for this commodity. Indatraline bears US NLM identifiers UMLS ID C0065216 and NCI Concept Code C83797. SMILES: Clc1cc(C2CC(NC)c3c2cccc3)ccc1Cl.

About UNSPSC 51293502

UNSPSC 51293502 Indatraline is a Commodity code that covers pharmaceutical and medical-supply procurement, though recent state and local activity under this code shows a mismatch between the nominal category name and actual buying patterns. The single recent opportunity identified reflects demand for naloxone and drug deactivation systems rather than indatraline specifically, suggesting the code may be applied inconsistently or the opportunity was mistagged. State and local governments soliciting under this code appear to be county health departments and community health entities focused on opioid-response and harm-reduction initiatives, procuring emergency medications and related equipment through competitive bidding processes.

Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The bid response deadline was July 26, 2023, with vendors required to submit electronic bids through the county's e-Procurement Portal, provide unit costs for each line item, maintain drug-free workplace and E-Verify compliance, and include all shipping and delivery costs in their proposals. The contract carries a two-year initial term with an option for one-year renewal and includes a three-month probationary period. The procurement was potentially funded through FEMA, introducing federal compliance requirements such as adherence to the Clean Air Act and Federal Water Pollution Control Act. Geographic activity under this code is limited; recent solicitation data supports only Florida activity, and the narrow opportunity base suggests this code sees modest state and local procurement volume overall.

Quick answers

What is UNSPSC 51293502?

UNSPSC 51293502 is Indatraline, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51293502?

UNSPSC 51293502 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51293502

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code